Get the Stockscreener App
3.46
1.76%
0.06
After Hours:
3.46
Pluri Inc stock is traded at $3.46, with a volume of 2,023.
It is up +1.76% in the last 24 hours and up +2.03% over the past month.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
See More
Previous Close:
$3.40
Open:
$3.4
24h Volume:
2,023
Relative Volume:
0.25
Market Cap:
$34.78M
Revenue:
$1.34M
Net Income/Loss:
$-27.11M
P/E Ratio:
-1.0627
EPS:
-3.2559
Net Cash Flow:
$-22.01M
1W Performance:
+2.98%
1M Performance:
+2.03%
6M Performance:
-23.22%
1Y Performance:
-7.24%
1-Day Range:
$3.355
$3.46
1-Week Range:
$3.22
$3.48
52-Week Range:
$2.82
$7.13
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
3.46 | 34.17M | 1.34M | -27.11M | -22.01M | -3.2559 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pluri Inc Stock (PLUR) Latest News
Is Pluri Inc stock influenced by commodity pricesMarket Activity Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Signal Recap: Will Pluri Inc outperform during market ralliesGap Down & Weekly Sector Rotation Insights - baoquankhu1.vn
Risk On: Can Pluri Inc maintain its current growth rateWeekly Trade Recap & Technical Pattern Based Signals - baoquankhu1.vn
Aug Selloffs: Will Pluri Inc outperform during market ralliesPortfolio Update Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
ETF Watch: Is Pluri Inc stock influenced by commodity prices2026 Key Lessons & Expert-Curated Trade Recommendations - baoquankhu1.vn
Germany Stocks: Research Stocks from Germany Stock Market - GuruFocus
Aug Final Week: Is Pluri Inc benefiting from innovation trendsWeekly Stock Summary & Daily Entry Point Alerts - baoquankhu1.vn
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
PLUR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Asia Stocks: Research Stocks from Asia Stock Market - GuruFocus
Aug Big Picture: Is Pluri Inc a defensive stockTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
SRXH PE Ratio & Valuation, Is SRXH Overvalued - Intellectia AI
Pluri Inc. (PLUR) Stock Price Quote Today & Current Price Chart - Capital.com
SRXH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Quarterly Earnings: How does Pluri Inc compare to its peers2026 Volume Leaders & Capital Efficient Trade Techniques - baoquankhu1.vn
Europe Stocks: Research Stocks from Europe Stock Market - GuruFocus
Big Money Moves: Can Pluri Inc maintain its current growth rate2026 Breakouts & Breakdowns & Smart Investment Allocation Tips - baoquankhu1.vn
Portfolio Update: Will Pluri Inc outperform during market rallies2026 PostEarnings & Community Driven Trade Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - gurufocus.com
NextPlat approves 1-for-10 reverse stock split effective April 6 - Investing.com Australia
Pluri Announces Financing Through Unregistered Equity Securities Deal - TipRanks
Pluri Raises $2.5 Million in Private Placement With Chutzpah Holdings; Issues Shares and Warrants - TradingView
Pluri (NASDAQ: PLUR) sells shares and warrants in $2.5M private deal - Stock Titan
Pluri (PLUR) Secures Additional $2.5M Investment from Board Chai - GuruFocus
Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement - MarketScreener
Pluri's chairman paid 30% above market in a new $2.5M buy - Stock Titan
Aug PostEarnings: How do insiders feel about Pluri IncIPO Watch & Expert Verified Movement Alerts - baoquankhu1.vn
Pluri Inc. announced that it expects to receive $2.5 million in funding - marketscreener.com
If You Invested $1,000 in Pluri Inc (PLUR) - Stock Titan
PLUR PE Ratio & Valuation, Is PLUR Overvalued - Intellectia AI
S P Trends: Will Pluri Inc outperform during market rallies2026 Geopolitical Influence & High Conviction Trade Alerts - baoquankhu1.vn
Pluristem Secures Nasdaq Listing and Expands Intellectual Property in China () - aktiencheck.de
Plurilock Security Inc.: Plurilock Provides Corporate Update - FinanzNachrichten.de
Pluri Regains Nasdaq Compliance, Restoring Listing Stability - TipRanks
Panic Selling: Is Pluri Inc stock a value trapPortfolio Update Summary & High Conviction Trade Alerts - baoquankhu1.vn
Pluri regains Nasdaq compliance after meeting market value requirement By Investing.com - Investing.com UK
Pluri regains Nasdaq compliance after meeting market value requirement - Investing.com
Pluri regains Nasdaq listing compliance after MVLS threshold met - TradingView
Pluri (NASDAQ: PLUR) regains key Nasdaq listing standard compliance - Stock Titan
Options Flow: Does Pluri Inc have strong fundamentals2025 Trading Volume Trends & Fast Moving Stock Trade Plans - baoquankhu1.vn
Volume Report: What are Pluri Incs technical support levelsPortfolio Risk Report & Reliable Trade Execution Plans - baoquankhu1.vn
Insider Sell: Is Pluri Inc part of any major indexJuly 2025 Setups & Community Verified Swing Trade Signals - baoquankhu1.vn
MSN Money - MSN
Pluri Biotech Secures China Patent for Immune Cell Tech - Contract Pharma
Pluri (PLUR) Secures Key Patent in China for 3D Cell Expansion T - GuruFocus
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent - The Manila Times
Pluri lands China patent for tech to mass-produce immune cells - Stock Titan
Pluri Inc. (NASDAQ:PLUR) Sees Large Increase in Short Interest - Defense World
Can Pluri Inc. (4DX) stock stage a strong rebound this quarterJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - mfd.ru
Why analysts maintain buy rating on Pluri Inc. (4DX) stockTrade Risk Assessment & Risk Managed Investment Signals - mfd.ru
Pluri: Overview of Second Quarter Financial Results - Bitget
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):